Cited by CrossRef (6)

  1. Peter M. Nilsson. Early Vascular Aging (EVA). .
    https://doi.org/10.1016/B978-0-443-15512-3.00011-8
  2. Wenru Shang, Xu Hui, Meixuan Li, Junjie Ren, Xinyu Huang, Jing Li, Xiaoqin Wang, Qi Wang, Yanfang Ma, Eva Madrid, Javier Bracchiglione, Lei Jiang, Kehu Yang, Liang Yao. Pharmacological treatments for adults with overweight and obesity without diabetes. 2024;2024
    https://doi.org/10.1002/14651858.CD015861
  3. Abdulbaril Olagunju, Naser Yamani, Dorothy Kenny, Martina Mookadam, Farouk Mookadam, Samuel Unzek. Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis. World J Cardiol 2022;14:599
    https://doi.org/10.4330/wjc.v14.i11.599
  4. Peter M. Nilsson, Hannes Holm, Martin Magnusson. Hypertension and Heart Failure. 2022.
    https://doi.org/10.1007/978-3-031-39315-0_23
  5. Caraline Watkins, Zoe Schilling, Kevin Kawalec, Darrell Hulisz. Does GLP-RA Plus an SGLT2 Inhibitor Yield Greater Weight Loss in Patients with Obesity and Diabetes than Monotherapy?. Curr Cardiovasc Risk Rep 2023;17:155
    https://doi.org/10.1007/s12170-023-00724-3
  6. Eun-Jung Rhee. A Report of Journal of Obesity and Metabolic Syndrome in the Last 3 Years of Upheaval. Journal of Obesity & Metabolic Syndrome 2022;31:4
    https://doi.org/10.7570/jomes22020